Dyne Therapeutics DYN
NASDAQ DYN
$17.99 +0.07 (+0.39%)
As of: Nov 11, 2026 · 3:59 PM EST

Dyne Therapeutics (DYN) Total Non-Current Liabilities (2019 - 2026)

Updated

Dyne Therapeutics (DYN) recorded Total Non-Current Liabilities of $14.61 million in Q3 2020.

Analysis

Dyne Therapeutics (DYN) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2019, Dyne Therapeutics reported Total Non-Current Liabilities of $2.36 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 102.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 117.60 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -36.84 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 36.05 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 96.04 Bn
10 Dyne Therapeutics 3.36 Bn -757.60 Mn - 303.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 303.30 Mn
Dec 31, 2025 214.83 Mn
Dec 31, 2024 80.14 Mn
Dec 31, 2023 72.23 Mn
Dec 31, 2022 49.79 Mn
Dec 31, 2021 55.13 Mn
Sep 30, 2020 14.61 Mn
Dec 31, 2019 2.36 Mn
API Access

Dyne Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=DYN&period=max&api_key=YOUR_API_KEY